Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
IMRX
Stock Latest News
Market News
3 Best Stocks to Buy Now, 3/10/2026, According to Top Analysts
5d ago
EVAX
IMRX
Premium
Market News
3 Best Stocks to Buy Today, 3/9/2026, According to Top Analysts
7d ago
MWH
AKTS
Premium
The Fly
Immuneering price target lowered to $12 from $13 at Piper Sandler
7d ago
IMRX
Premium
Ratings
Advancing Atebimetinib Pipeline and Strong Cash Runway Underpin Buy Rating on Immuneering
7d ago
IMRX
Premium
The Fly
Midday Fly By: Rising oil prices, falling employment sink stocks
10d ago
BA
BX
Premium
The Fly
Immuneering reports Q4 EPS (18), consensus (31c)
10d ago
IMRX
Premium
The Fly
Immuneering sees cash runway into 2029
10d ago
IMRX
Premium
The Fly
Immuneering updated 12-month data for atebimetinib ‘encouraging,’ says Leerink
2M ago
IMRX
RVMD
Premium
The Fly
Midday Fly By: Defense stocks surge on Trump budget request
2M ago
F
AA
Premium
Ratings
Immuneering: Phase 2a Strength of Atebimetinib in First-Line Pancreatic Cancer Supports Buy Rating Despite Competitive Overhang
2M ago
IMRX
Premium
The Fly
Closing Bell Movers: Defense stocks surge on Trump military budget comments
2M ago
FC
GD
Premium
The Fly
Immuneering reports ‘positive’ survival, safety data from atebimetinib trial
2M ago
IMRX
Premium
Company Announcements
Immuneering Reports Strong Phase 2a Pancreatic Cancer Survival Data
2M ago
8K
IMRX
Premium
The Fly
Immuneering management to meet with Oppenheimer
2M ago
IMRX
Premium
The Fly
Immuneering to announce OS data from Phase 2a trial of atebimetinib, mGnP
3M ago
IMRX
Premium
The Fly
Immuneering on track to dose first patient in pancreatic cancer trial in 2026
3M ago
IMRX
Premium
The Fly
Immuneering to be added to the Nasdaq Biotechnology Index
3M ago
IMRX
Premium
Company Announcements
Immuneering Corp. Shines in Positive Earnings Call
4M ago
IMRX
Premium
Ratings
Promising Potential of Immuneering’s Atebimetinib: Analyst Recommends ‘Buy’ Rating
4M ago
IMRX
Premium
Company Announcements
Immuneering Corp. Reports Strong Q3 2025 Progress
4M ago
IMRX
Premium
The Fly
Immuneering reports Q3 EPS (38c), consensus (39c)
4M ago
IMRX
Premium
The Fly
Immuneering expects cash to fund operations into 2029
4M ago
IMRX
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
